Increased Cardiovascular Disease Risk Frequent in HIV-Infected Teens

FEBRUARY 20, 2014
A significant proportion of teens who were perinatally infected with HIV are at an increased risk for developing atherosclerotic cardiovascular disease, according to a recent study published online on December 23, 2013, in Circulation: Journal of the American Heart Association.

HIV-infected adolescents may be more likely to develop cardiovascular disease, due to long-term exposure to HIV and antiretroviral therapy. To test this theory, the study enrolled 165 teenagers with HIV and used the Pathobiological Determinant of Atherosclerosis in Youth (PDAY) to calculate their risk of having an advanced atherosclerotic lesion in the coronary arteries and abdominal aorta.

The PDAY scores indicated that 48% of the adolescents were at an elevated risk for lesion in the coronary arteries and 24% were at an elevated risk for lesion in the abdominal aorta. Teens who had a history of an AIDS-defining condition and those who had used a boosted protease inhibitor longer were more likely to have an increased risk for both coronary artery and abdominal aorta lesions.

Although the study was limited by a small sample size and the inability to confirm PDAY scores with noninvasive assessments of cardiovascular disease or events, the authors conclude that PDAY scores may help to identify highrisk adolescents who may benefit from early interventions.

SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.